The ABPI has produced this sourcebook to support pharmaceutical companies in working successfully and collaboratively with patients and patient organizations.
Pharmaceutical companies are doing everything in their power to avoid disruption to the supply of medicines in all Brexit scenarios. This includes increasing stocks of medicine in the UK, changing supply routes, transferring medicine licenses and duplicating testing in the EU.
Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history. Every year, 2 – 3 million lives are saved across the world because of immunisation.
The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost effective before they can be used in the NHS.
Illness never sleeps. It grows, mutates and causes pain and suffering. Disease never takes a break, so neither do we. Because people fighting disease deserve the best chance to live. We won’t rest until people around the world see a brighter tomorrow.
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.
13 June 2019
The ABPI has published a new guide for pharmaceutical companies working with patients.
11 June 2019
The ABPI welcomes the news of the Government’s decision to reject three significant recommendations made by the Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) group following consultation with charities, patient groups, health bodies and organisations, and industry.
06 June 2019
There has been much discussion in recent days on medicines pricing in the UK. The UK has some of the most robust processes in the world for ensuring value for money on medicines.
04 June 2019
Today, 4 June, sees the unveiling of the UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) at a BIO reception in Philadelphia.
05 June 2019
Dr Richard Torbett provides an ABPI view on medicines pricing in the UK and the current situation between NHS England and Vertex on access to Orkambi for Cystic Fibrosis patients
23 May 2019
Today (23 May), the ABPI and the AHSN Network publish a new guide to cross-sector working between NHS Sustainable Transformation Partnerships (STPs), Integrated Care Systems (ICSs) and industry. The guide sets out governance and process recommendations to make collaboration more straightforward.
AHSN Network Chair Dr Séamus O’Neill and ABPI CEO Mike Thompson explain its importance.